Oct 06, 2023 21:00 JST

Source: Olympus

Olympus Names Dr. John de Csepel as Chief Medical Officer
Driving the Medical and Scientific Affairs Division to provide the highest level of patient access and safety

Olympus Corporation (Olympus), a global MedTech company committed to making people's lives healthier, safer and more fulfilling, named Dr. John de Csepel to the role of Chief Medical Officer (CMO), effective immediately.

In this role, John will report to CEO Stefan Kaufmann and drive the globally integrated Medical and Scientific Affairs Division (MSA) with a wealth of experience and remarkable track record in healthcare. Olympus is devoted to developing safe medical devices with demonstrable clinical and economic value to reduce the social burden of healthcare costs while improving healthcare outcomes for all.

Dr. John de Csepel
Dr. John de Csepel

"As a leading global MedTech company, we must deliver optimal medical care that prioritizes patient safety to meet the expectations of our stakeholders. Today, I am delighted to announce an exciting new leader to take the team to even greater heights," said Shigeto Ohtsuki, Olympus Chief Human Resources Officer. "We look forward to the innovative ideas, expertise, and leadership that Dr. de Csepel will bring us as we continue contributing to the advancement of healthcare."

The MSA team aims to improve patient outcomes by elevating the standard of care through minimally invasive solutions across targeted diseases while delivering above-market, sustainable growth.

John joins Olympus from Medtronic, where he most recently served as the Global Regions Chief Medical Officer. He played a pivotal role in driving innovative relationships with healthcare providers and enhancing patient access to care through his leadership in clinical research and medical science. Before that, he headed the Medical Affairs teams at both Barrx Medical and Covidien's Surgical business, demonstrating exceptional leadership and expertise in the MedTech industry. Concurrent with his management experience, he has worked as a volunteer war surgeon for Doctors Without Borders (Médecins Sans Frontiéres) from 2006 through 2014 and since then as a New York City trauma surgeon on the weekends.

John holds a bachelor's degree in business administration and a doctorate in medicine from Georgetown University, Washington D.C. He was a General Surgery Resident and Laparoscopic Surgery Fellow at the Mount Sinai School of Medicine in New York and subsequently served as Chief of Minimally Invasive of Surgery at New York's Saint Vincent's Hospital. He continues to reside in New York, U.S.A.

About Olympus

At Olympus, we are committed to Our Purpose of making people's lives healthier, safer and more fulfilling. As a global medical technology company, we partner with healthcare professionals to provide best-in-class solutions and services for early detection, diagnosis and minimally invasive treatment, aiming to improve patient outcomes by elevating the standard of care in targeted disease states. For more than 100 years, Olympus has pursued a goal of contributing to society by producing products designed with the purpose of delivering optimal outcomes for its customers around the world. For more information, visit https://www.olympus-global.com/ and follow our global X account: @Olympus_Corp.

Media contact:
Nao Tsukamoto
Tel: +81-80-8853-9124
Mail: Global-Public_Relations@olympus.com

Olympus Corp [TYO: 7733] [ADR: OLYMY] [STU: OLY1] [FRA: OLYS] https://www.olympus-global.com

Source: Olympus
Sectors: Healthcare & Pharm, HR, MedTech

Copyright ©2024 JCN Newswire. All rights reserved. A division of Japan Corporate News Network.

Related Press Release


NTT and Olympus Joint Demonstration Shows IOWN APN's Low-latency Capability Can Be Used for Real-time Diagnosis and Treatment on a Remote Server to Realize World's First Cloud Endoscopy System
November 19 2024 14:30 JST
 
Olympus Launches VISERA S, a New Imaging Platform
September 30 2024 14:00 JST
 
Olympus Launches New 4K Camera Head for Urological Endoscopy
September 20 2024 14:00 JST
 
Olympus Enhances Innovation Capabilities by Expanding R&D to Hyderabad, India
June 12 2024 10:00 JST
 
NTT and Olympus Begin World's First Joint Demonstration Experiment of Cloud Endoscopy System
March 27 2024 14:00 JST
 
Olympus Closes the Acquisition of Korean Gastrointestinal Stent Company, Taewoong Medical Co., Ltd
January 24 2024 14:00 JST
 
Olympus Named to Dow Jones Sustainability World Index for Three Consecutive Years
December 11 2023 10:00 JST
 
Vesica AI Selected as Winner of Inaugural Olympus Asia Pacific Innovation Program
December 07 2023 10:00 JST
 
Olympus's Net-Zero Targets Approved by SBTi
November 30 2023 10:00 JST
 
Olympus to Launch Development Support Project in Kenya for the Diagnosis of Gastrointestinal Diseases
July 20 2023 10:00 JST
 
More Press release >>

Latest Press Release


More Latest Release >>